TY  - JOUR

T1  - The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

JO  - Cancer Discovery

UR  - https://doi.org/10.1158/2159-8290.cd-19-1167

PY  - 2020/01/09

AU  - Hallin J

AU  - Engstrom LD

AU  - Hargis L

AU  - Calinisan A

AU  - Aranda R

AU  - Briere DM

AU  - Sudhakar N

AU  - Bowcut V

AU  - Baer BR

AU  - Ballard JA

AU  - Burkard MR et al

ED  - 

DO  - DOI: 10.1158/2159-8290.cd-19-1167

PB  - American Association for Cancer Research (AACR)

VL  - 10

IS  - 1

SP  - 54

EP  - 71

Y2  - 2026/03/17

ER  -